Joel S. Marcus - Nov 7, 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role: Director
Signature: /s/ Lawrence J. Hineline, Attorney-in-fact
Stock symbol: ITCI
Transactions as of: Nov 7, 2022
Transactions value $: -$523,023
Form type: 4
Date filed: 11/8/2022, 03:12 PM
Previous filing: Sep 16, 2022
Next filing: Dec 7, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITCI	Common Stock	Sale	-$262K	-5K	-11.3%	$52.49	39.2K	Nov 7, 2022	Direct
transaction	ITCI	Common Stock	Sale	-$261K	-5K	-12.74%	$52.11	34.2K	Nov 7, 2022	Direct
holding	ITCI	Common Stock						10K	Nov 7, 2022	See Footnote	F1

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents securities held of record by Alexandria Real Estate Equities, Inc. The reporting person is the Executive Chairman & Founder of Alexandria Real Estate Equities, Inc. and may therefore be deemed to have voting and investment power with respect to the shares owned by Alexandria Real Estate Equities, Inc. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.

Content

Represents securities held of record by Alexandria Real Estate Equities, Inc. The reporting person is the Executive Chairman & Founder of Alexandria Real Estate Equities, Inc. and may therefore be deemed to have voting and investment power with respect to the shares owned by Alexandria Real Estate Equities, Inc. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.